Stay updated on GVAX & Pembrolizumab in MMR-p CRC Clinical Trial
Sign up to get notified when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.

Latest updates to the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page
- ChecktodayChange DetectedThe page now displays a 403 Forbidden error with a minimal header and navigation. It replaces the usual study content, indicating that access to the study details is blocked.SummaryDifference19%

- Check7 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0. This indicates a refresh or minor update to the page content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page's revision tag was updated to v3.6.6, replacing the previous v3.6.5 in the footer. This appears to be a versioning/metadata update rather than a change to substantive content or features.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page now shows a new revision label v3.6.5 replacing the previous v3.6.4, indicating a minor backend or UI update without changes to the study details or content.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4 on the page, signaling a newer revision tag. This is an administrative update to the page rather than a change to study content or user-facing information.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.3, indicating an update to the page framework.SummaryDifference0.1%

Stay in the know with updates to GVAX & Pembrolizumab in MMR-p CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.